Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones

Bioorg Med Chem. 2016 May 15;24(10):2206-14. doi: 10.1016/j.bmc.2016.03.056. Epub 2016 Mar 30.

Abstract

A series of 1-acyl-3,5-bis(benzylidene)-4-piperidones 3-7 were designed and synthesized as novel cytotoxic agents. These compounds displayed potent cytotoxic properties towards human Molt4/C8, CEM, HSC-2, HSC-3 and HSC-4 neoplasms and also to murine L1210 cells. The majority of the compounds have sub-micromolar or very low micromolar IC50 and CC50 values and are significantly more potent than the reference alkylating drug melphalan. Evaluation of these compounds against non-malignant HGF and HPLF cells revealed the tumour-specific toxicity. In particular, 3e emerged as a promising lead cytotoxic agent which caused apoptosis and PARP1 cleavage in HSC-2 cells.

Keywords: 4-Piperidone; Cytotoxicity; Structure–activity relationships; Tumour-specific toxicity; α,β-Unsaturated ketone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Cell Line
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Mice
  • Neoplasms / drug therapy
  • Piperidones / chemistry*
  • Piperidones / pharmacology*
  • Structure-Activity Relationship

Substances

  • 3,5-bis(benzylidene)-4-piperidone
  • Antineoplastic Agents
  • Piperidones

Grants and funding